Dune Medical Devices · raw details

Dune Medical Devices has developed tissue characterization technology that can be used for a broad range of diagnostic and therapeutic applications and offers surgeons and radiologists the ability to detect cancer in real time. The company's MarginProbe System delivers real-time cancer detection in the operating room through a simple assessment of the margin of excised tissue. The key element of the MarginProbe System is its Fringe Field Sensor. Positioned at the tip of the probe, the highly responsive sensor emits a precisely controlled electromagnetic field and captures the tissue's response. The sensor identifies signals in close range to the edge of the tissue, the critical focus of margin assessment. The company is also developing a smart biopsy system. The system will expand the company's surgical oncology portfolio to include a soft tissue biopsy system with its first indication in breast tissue. This project has received funding from the European Union's Horizon 2020 research and innovation program.